← Back to Search

Balloon Catheter

Lacrosse NSE ALPHA coronary dilatation catheter for Coronary Artery Stenosis (EXPANSE-PTCA Trial)

N/A
Waitlist Available
Led By Mitchell Krucoff, MD
Research Sponsored by Infraredx
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up procedural
Awards & highlights

EXPANSE-PTCA Trial Summary

This trial is testing a new coronary dilatation catheter to see if it is safe and effective in people with blocked coronary arteries.

Eligible Conditions
  • Coronary Artery Stenosis
  • In-Stent Restenosis

EXPANSE-PTCA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~procedural
This trial's timeline: 3 weeks for screening, Varies for treatment, and procedural for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Procedure Success
Secondary outcome measures
Change in Minimum Lumen Diameter (MLD) Following Use of the Lacrosse NSE ALPHA Catheter
Device Procedural Success (Per Target Lesion)
Occurrence of Lacrosse NSE ALPHA Balloon Rupture
+4 more

EXPANSE-PTCA Trial Design

1Treatment groups
Experimental Treatment
Group I: Lacrosse NSE ALPHA percutaneous coronary intervention (PCI)Experimental Treatment1 Intervention
Percutaneous coronary intervention (PCI) in which at least one Lacrosse NSE ALPHA device is used.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lacrosse NSE ALPHA coronary dilatation catheter
2021
N/A
~200

Find a Location

Who is running the clinical trial?

InfraredxLead Sponsor
10 Previous Clinical Trials
4,833 Total Patients Enrolled
Bright Research PartnersIndustry Sponsor
13 Previous Clinical Trials
1,554 Total Patients Enrolled
Mitchell Krucoff, MDPrincipal InvestigatorDuke University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~60 spots leftby Apr 2025